Transgender women and men who have sex with men benefit most from pre-exposure antiretroviral drugs, whether or not they perceive their partners to be HIV negative, according to new research.
<p>The U.S. Food and Drug Administration has called for an assessment of potential neurocognitive side effects of an experimental cholesterol drug being developed by Regeneron and Sanofi, Sanofi said...